Torrent Pharmaceuticals Limited has once again expanded its recall of Losartan potassium tablets and Losartan potassium/hydrochlorothiazide tablets, the Food and Drug Administration announced Thursday.

The company has added an additional 36 lots of Losartan potassium tablets and 68 lots of Losartan potassium/hydrochlorothiazide tablets.

>> Read more trending news

The recall is due once again to an impurity called N-Methylnitrosobutric acid or NMBA.

The recalled lots have more NMBA than what is acceptable for daily intake set by the FDA.

Consumers with medical questions connected to the recall are being instructed to call Torrent Pharmaceuticals at 1-800-912-9561 or email Medinfo.Torrent@apcerls.com.

For more information, including the complete list of batch numbers included with the recall's expansion, click here.

About the Author

Featured

In this file photo from October 2024, Atlanta Braves outfielder Jorge Soler and teammates react after losing to the San Diego Padres 5-4 in San Diego. The Braves and Soler, who now plays for the Los Angeles Angels, face a lawsuit by a fan injured at a 2021 World Series game at Truist Park in Atlanta. (Jason Getz/AJC)

Credit: Jason.Getz@ajc.com